AU2003201618B2 - Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours - Google Patents

Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours Download PDF

Info

Publication number
AU2003201618B2
AU2003201618B2 AU2003201618A AU2003201618A AU2003201618B2 AU 2003201618 B2 AU2003201618 B2 AU 2003201618B2 AU 2003201618 A AU2003201618 A AU 2003201618A AU 2003201618 A AU2003201618 A AU 2003201618A AU 2003201618 B2 AU2003201618 B2 AU 2003201618B2
Authority
AU
Australia
Prior art keywords
use according
biomaterial
hyaluronic acid
group
tumour
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003201618A
Other languages
English (en)
Other versions
AU2003201618A1 (en
Inventor
Norbert E Fusenig
Alessandra Pavesio
Hans-Jurgen Stark
Michael Willhauck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Fidia Farmaceutici SpA
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Fidia Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ, Fidia Farmaceutici SpA filed Critical Deutsches Krebsforschungszentrum DKFZ
Publication of AU2003201618A1 publication Critical patent/AU2003201618A1/en
Application granted granted Critical
Publication of AU2003201618B2 publication Critical patent/AU2003201618B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003201618A 2002-01-11 2003-01-07 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours Ceased AU2003201618B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2002PD000003A ITPD20020003A1 (it) 2002-01-11 2002-01-11 Biomateriali a base di acido ialuronico come terapia anti-angiogenicanella cura dei tumori.
IT2002A000003 2002-01-11
PCT/EP2003/000078 WO2003057203A2 (en) 2002-01-11 2003-01-07 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours

Publications (2)

Publication Number Publication Date
AU2003201618A1 AU2003201618A1 (en) 2003-07-24
AU2003201618B2 true AU2003201618B2 (en) 2008-11-06

Family

ID=11452500

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003201618A Ceased AU2003201618B2 (en) 2002-01-11 2003-01-07 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours

Country Status (12)

Country Link
US (1) US7838510B2 (enExample)
EP (1) EP1463541B1 (enExample)
JP (1) JP4603263B2 (enExample)
AT (1) ATE448809T1 (enExample)
AU (1) AU2003201618B2 (enExample)
CA (1) CA2472880C (enExample)
DE (1) DE60330113D1 (enExample)
DK (1) DK1463541T3 (enExample)
ES (1) ES2334497T3 (enExample)
IT (1) ITPD20020003A1 (enExample)
PT (1) PT1463541E (enExample)
WO (1) WO2003057203A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20040312A1 (it) * 2004-12-15 2005-03-15 Fidia Advanced Biopolymers Srl Protesi e o supporto per la sostituzione, riparazione, rigenerazione del menisco

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341745A1 (en) * 1988-05-13 1989-11-15 FIDIA S.p.A. Crosslinked carboxy polysaccharides
US5520916A (en) * 1991-12-18 1996-05-28 M.U.R.S.T. (Italian Ministry For Universities And Scientific And Technological Research) Non-woven fabric material comprising hyaluronic acid derivatives
WO1999061080A1 (en) * 1998-05-27 1999-12-02 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
WO2000001733A1 (en) * 1998-07-06 2000-01-13 Fidia Advanced Biopolymers S.R.L. Amides of hyaluronic acid and the derivatives thereof and a process for their preparation
WO2000054762A2 (en) * 1999-03-15 2000-09-21 Trustees Of Boston University Use of cross linked polysaccharides for the inhibition of angiogenesis
WO2002018448A2 (en) * 2000-08-31 2002-03-07 Fidia Farmaceutici S.P.A. Percarboxylated polysaccharides, and a process for their preparation
WO2002018450A1 (en) * 2000-08-31 2002-03-07 Fidia Farmaceutici S.P.A. New cross-linked derivatives of hyaluronic acid
WO2002041877A1 (en) * 2000-10-24 2002-05-30 Clear Solutions Biotech, Inc. Sodium hyaluronate microspheres

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6117A (ja) * 1984-06-11 1986-01-06 Seikagaku Kogyo Co Ltd ムコ多糖系癌転移抑制剤
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US5143724A (en) 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
CA2094203A1 (en) * 1993-04-16 1994-10-17 Derek A. Willoughby Inhibition of angiogenesis
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
IL123500A (en) * 1995-08-29 2003-06-24 Fidia Advanced Biopolymers Srl Composite biomaterials for preventing post-surgical adhesions of tissues
US6579978B1 (en) * 1997-04-04 2003-06-17 Fidia Farmaceuti S.P.A. Biomaterials comprising N-sulphated hyaluronic acid compounds or derivatives thereof
IT1293484B1 (it) * 1997-06-11 1999-03-01 Fidia Advanced Biopolymers Srl Materiale biologico comprendente una efficiente coltura di cellule e una matrice tridimensionale biocompatibile e biodegradabile
CA2366604A1 (en) 1999-03-26 2000-10-05 The University Of Texas System Modulators of polysaccharides and uses thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341745A1 (en) * 1988-05-13 1989-11-15 FIDIA S.p.A. Crosslinked carboxy polysaccharides
US5520916A (en) * 1991-12-18 1996-05-28 M.U.R.S.T. (Italian Ministry For Universities And Scientific And Technological Research) Non-woven fabric material comprising hyaluronic acid derivatives
WO1999061080A1 (en) * 1998-05-27 1999-12-02 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
WO2000001733A1 (en) * 1998-07-06 2000-01-13 Fidia Advanced Biopolymers S.R.L. Amides of hyaluronic acid and the derivatives thereof and a process for their preparation
WO2000054762A2 (en) * 1999-03-15 2000-09-21 Trustees Of Boston University Use of cross linked polysaccharides for the inhibition of angiogenesis
WO2002018448A2 (en) * 2000-08-31 2002-03-07 Fidia Farmaceutici S.P.A. Percarboxylated polysaccharides, and a process for their preparation
WO2002018450A1 (en) * 2000-08-31 2002-03-07 Fidia Farmaceutici S.P.A. New cross-linked derivatives of hyaluronic acid
WO2002041877A1 (en) * 2000-10-24 2002-05-30 Clear Solutions Biotech, Inc. Sodium hyaluronate microspheres

Also Published As

Publication number Publication date
US7838510B2 (en) 2010-11-23
ATE448809T1 (de) 2009-12-15
EP1463541B1 (en) 2009-11-18
ITPD20020003A1 (it) 2003-07-11
US20050037049A1 (en) 2005-02-17
CA2472880A1 (en) 2003-07-17
DK1463541T3 (da) 2010-03-08
ES2334497T3 (es) 2010-03-11
WO2003057203A3 (en) 2003-12-31
DE60330113D1 (de) 2009-12-31
WO2003057203A2 (en) 2003-07-17
JP4603263B2 (ja) 2010-12-22
EP1463541A2 (en) 2004-10-06
JP2005524619A (ja) 2005-08-18
CA2472880C (en) 2011-08-16
AU2003201618A1 (en) 2003-07-24
PT1463541E (pt) 2010-01-07

Similar Documents

Publication Publication Date Title
Khaing et al. High molecular weight hyaluronic acid limits astrocyte activation and scar formation after spinal cord injury
Zhu et al. Hyaluronic acid and polyethylene glycol hybrid hydrogel encapsulating nanogel with hemostasis and sustainable antibacterial property for wound healing
Chen et al. Zero-order controlled release of BMP2-derived peptide P24 from the chitosan scaffold by chemical grafting modification technique for promotion of osteogenesis in vitro and enhancement of bone repair in vivo
Guha Ray et al. Surface modification of eggshell membrane with electrospun chitosan/polycaprolactone nanofibers for enhanced dermal wound healing
Cui et al. Hyaluronic acid hydrogel immobilized with RGD peptides for brain tissue engineering
Xu et al. Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three‐dimensional lung cancer xenograft model
US20090269406A1 (en) Therapeutic uses of biocompatible biogel compositions
Xu et al. Injectable gelatin hydrogel suppresses inflammation and enhances functional recovery in a mouse model of intracerebral hemorrhage
Yuan et al. Chitosan/LiCl composite scaffolds promote skin regeneration in full-thickness loss
Abed et al. Influence of polysaccharide composition on the biocompatibility of pullulan/dextran‐based hydrogels
Laursen et al. Electrospun nanofiber mesh with connective tissue growth factor and mesenchymal stem cells for pelvic floor repair: Long‐term study
Daubiné et al. Nanostructured polyelectrolyte multilayer drug delivery systems for bone metastasis prevention
Choi et al. Vascular endothelial growth factor incorporated multilayer film induces preangiogenesis in endothelial cells
Perikaruppan et al. Cuttlefish bone derived hydroxyapatite-integrated alginate membrane for hemostasis and regeneration
AU2003201618B2 (en) Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours
Westwood et al. The road after cancer: biomaterials and tissue engineering approaches to mediate the tumor microenvironment post-cancer treatment
Yuan et al. Substrate-independent polymer coating with stimuli-responsive dexamethasone release for on-demand fibrosis inhibition
KR101655435B1 (ko) 연조직과 경조직 동시 재생을 위한 다공성, 생분해성 및 서방성 특성을 가진 다층 하이브리드 지지체
Di et al. The utilization of chitosan/Bletilla striata hydrogels to elevate anti-adhesion, anti-inflammatory and pro-angiogenesis properties of polypropylene mesh in abdominal wall repair
WO2019181294A1 (ja) スルホン化セルロースナノファイバーを含むハイドロゲル
Xiong et al. [Retracted] Breast Cancer Cells Metastasize to the Tissue‐Engineered Premetastatic Niche by Using an Osteoid‐Formed Polycaprolactone/Nanohydroxyapatite Scaffold
Harmon et al. Effects of fibrin pad hemostat on the wound healing process in vivo and in vitro
Forde et al. Biomaterial-mediated drug delivery in primary and metastatic cancers of the bone
Augustine et al. Control Release and Diffusion-Reaction Kinetics of Genipin-Eluting Fibers Using an in Vitro Aneurysm Flow Model
Giraldo Solano Development of a trap to attract and eliminate cancer cells infiltrated into the brain

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired